Plain-English translation of NCT07245121 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing perineural prolotherapy—a treatment where a glucose solution (dextrose 5%) is injected around the small nerves that supply the knee joint—to see if it can reduce chronic pain from knee osteoarthritis. The treatment uses ultrasound guidance to place the injections precisely at four different nerves around the knee. Researchers believe the glucose solution may work by calming pain signals and reducing inflammation around these nerves, offering a gentler alternative to other pain treatments.
Standard treatments for knee arthritis pain have limited effectiveness and some can cause serious side effects. This trial exists to test whether this new approach—using a glucose solution injected around intact nerves—can safely and effectively reduce pain for people who have not found relief with other conservative treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive ultrasound-guided injections around the four main nerves of your knee. Half of participants will receive injections of glucose solution plus numbing medication, and the other half will receive numbing medication alone. You will need reliable transportation to the hospital for your treatment visits and follow-up appointments to assess how well the treatment works for your pain and knee function.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Greece